h
PSC
reg
®
Home
Browse
All cell lines
All hiPSC lines
All hESC lines
Cell line providers
Research projects
Countries
Diseases
Publications
Clinical studies
Info
About hPSCreg
FAQ
Cell Registration
Glossary
Documents & Governance
How-To Videos
Fact Sheets
Naming Tool
Publishing your line
Structures
Registration Summary
Certification
Organoids
API
Export Data
SPARQL Guide
Contact
News
Privacy Policy
Terms of Use
Imprint
Login
Log-in
Sign up
Forgot your password?
This website uses cookies to keep track of login sessions and for internal Matomo Statistics. See our
Privacy Policy
for details.
This website uses cookies,
learn more
x
SDUKIi002-A
Registration Summary
:
A
P
E
C
IP-AP2, IP-AP2EXP25C1
The cell line is
not submitted
yet.
(only basic data is shown)
General
iPSC Line
hPSCreg name
SDUKIi002-A
Cite as:
When citing this cell line, please use the hPSCreg name (see
Naming Tool
) and the corresponding Research Resource ID (RRID).
SDUKIi002-A (RRID:CVCL_ZJ13)
Alternative name(s)
IP-AP2, IP-AP2EXP25C1
iPSC line type
Human induced pluripotent stem cell (hiPSC)
Similar iPSC lines
No similar lines found.
Last update
19th May 2021
User feedback
show/hide
Written by
on
Delete
No feedback available yet.
Login
to share your feedback, experiences or results with the research community.
Provider
Generator
University of Southern Denmark (SDU), Departement of Clinical Research (KI) (SDUKI)
External iPSC Databases
Cellosaurus
CVCL_ZJ13
Wikidata
Q98129496
General iPSC Information
Publications
Kamand M et al. Generation of human induced pluripotent stem cells (SDUKIi002-A) from a 22-year-old male diagnosed with autism spectrum disorder. Stem cell research. 2020 Jul;46:101834.
Kamand M et al. Derivation of induced pluripotent stem cells (SDUKIi003-A) from a 20-year-old male patient diagnosed with Asperger syndrome. Stem cell research. 2020 Oct;48:101974.
Kamand M et al. Generation of autism spectrum disorder patient-derived iPSC line SDUKIi004-A. Stem cell research. 2020 Dec;49:102038.
Kamand M et al. Establishment of an induced pluripotent stem (iPS) cell line (SDUKIi006-A) from a 21-year old male patient diagnosed with atypical autism disorder. Stem cell research. 2021 Mar;51:102185.
Miranda CC et al. A Dynamic 3D Aggregate-Based System for the Successful Expansion and Neural Induction of Human Pluripotent Stem Cells. Frontiers in cellular neuroscience. 2022;16:838217.
Ejlersen M et al. Superoxide dismutase isozymes in cerebral organoids from autism spectrum disorder patients. Journal of neural transmission (Vienna, Austria : 1996). 2022 Jun;129(5-6):617-626.
Pearson G et al. DNA Methylation Profiles of GAD1 in Human Cerebral Organoids of Autism Indicate Disrupted Epigenetic Regulation during Early Development. International journal of molecular sciences. 2022 Aug 16;23(16).
Ilieva M et al. Proteomic phenotype of cerebral organoids derived from autism spectrum disorder patients reveal disrupted energy metabolism, cellular components, and biological processes. Molecular psychiatry. 2022 Sep;27(9):3749-3759.
Kamand M et al. Generation and characterization of induced pluripotent stem (iPS) cell line (SDUCTi001-A) using fibroblasts derived from male-healthy donor. Stem cell research. 2022 Dec;65:102961.
Ariaei Armin et al. Induced pluripotent stem cells in autism research: a review of current advances and future directions. Egyptian Journal of Medical Human Genetics. 2026-02-24.
iPSC Derivation
General
Login to share your feedback, experiences or results with the research community.